ImmusanT, a clinical-stage company developing Nexvax2®, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet, presented data at the 2017 International Celiac Disease Symposium (ICDS) in Delhi, India for a potential blood test that could detect celiac disease with a single gluten challenge. This blood test could also […]
Celiac Disease Foundation is excited to host our 2nd Annual New York 5K Turkey Trot run/walk on Saturday, November 4, 2017, in Oyster Bay, NY. This year’s 5K event will again take place at Theodore Roosevelt Park.
Celiac Disease Foundation (CDF) and the Gluten Intolerance Group (GIG) are proud to announce a partnership that will improve the health and well-being of the celiac disease and gluten-free communities. n order to create the most comprehensive nonprofit
The CDF Clinical Trial Finder will make it easier for patients with celiac disease and non-celiac gluten/wheat sensitivity to enroll in clinical trials, enabling patients to better engage with medical research and accelerate development of drugs and treatments.
September 30, 2015 Washington, DC – Representatives Tim Ryan (OH-13) and Nita Lowey (NY-17) introduce the Gluten in Medicine Identification Act, which makes it easier to identify gluten in pharmaceutical products. This legislation requires drugs intended for humans use labels contain a statement identifying the source of any ingredient constituting or derived from a grain […]
At the International Celiac Disease Symposium (ICDS), celiac practitioners, researchers, patients, and leaders from around the world come together to share their collective knowledge and experience, and to propel forward the practices of treating and preventing gluten-related disorders. This is the one place to go to find the world’s experts in celiac disease, as they […]
Considering the rising number of cases of celiac disease, and its extremely detrimental effects on childhood development, leading to malabsorption and failure to thrive, it is becoming more necessary to find a means to properly diagnose young children.
Newly diagnosed patients with celiac disease were found to be at risk of metabolic syndrome and hepatic steatosis upon adopting a gluten-free diet. An in-depth nutritional assessment is recommended at diagnosis and during follow-up.